Jamie L Ryan1, Michael W Mellon, Katherine W F Junger, Elizabeth A Hente, Lee A Denson, Shehzad A Saeed, Kevin A Hommel. 1. *Department of Psychology, Oklahoma State University, Stillwater, Oklahoma; †Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; ‡Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; §Center for the Promotion of Treatment Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and ‖Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Abstract
BACKGROUND: Adjusting to symptom flares, treatment regimens, and side effects places youth with inflammatory bowel disease (IBD) at increased risk for emotional and behavioral problems and adverse disease outcomes. Implementation of psychosocial screening into clinical practice remains a challenge. This study examines the clinical utility of health-related quality of life (HRQOL) screening in predicting disease outcome and healthcare utilization. METHODS: One hundred twelve youth of 7 to 18 years diagnosed with IBD and their parents. Youth completed standardized measures of HRQOL and depression. Parents completed a proxy report of HRQOL. Pediatric gastroenterologists provided the Physician Global Assessment. Families were recruited from a pediatric gastroenterology clinic. Retrospective chart reviews examined disease outcome and healthcare utilization for 12 months after baseline measurement. RESULTS: Linear regressions, controlling for demographic and disease parameters, revealed that baseline measurement of youth and parent proxy-reported HRQOL predicted the number of IBD-related hospital admissions, gastroenterology clinic visits, emergency department visits, psychology clinic visits, telephone contacts, and pain management referrals over the next 12 months. Disease outcome was not significant. CONCLUSIONS: Lower HRQOL was predictive of increased healthcare utilization among youth with IBD. Regular HRQOL screening may be the impetus to providing better case management and allocating resources based on ongoing care needs and costs. Proactive interventions focused on patients with poor HRQOL may be an efficient approach to saving on healthcare costs and resource utilization.
BACKGROUND: Adjusting to symptom flares, treatment regimens, and side effects places youth with inflammatory bowel disease (IBD) at increased risk for emotional and behavioral problems and adverse disease outcomes. Implementation of psychosocial screening into clinical practice remains a challenge. This study examines the clinical utility of health-related quality of life (HRQOL) screening in predicting disease outcome and healthcare utilization. METHODS: One hundred twelve youth of 7 to 18 years diagnosed with IBD and their parents. Youth completed standardized measures of HRQOL and depression. Parents completed a proxy report of HRQOL. Pediatric gastroenterologists provided the Physician Global Assessment. Families were recruited from a pediatric gastroenterology clinic. Retrospective chart reviews examined disease outcome and healthcare utilization for 12 months after baseline measurement. RESULTS: Linear regressions, controlling for demographic and disease parameters, revealed that baseline measurement of youth and parent proxy-reported HRQOL predicted the number of IBD-related hospital admissions, gastroenterology clinic visits, emergency department visits, psychology clinic visits, telephone contacts, and pain management referrals over the next 12 months. Disease outcome was not significant. CONCLUSIONS: Lower HRQOL was predictive of increased healthcare utilization among youth with IBD. Regular HRQOL screening may be the impetus to providing better case management and allocating resources based on ongoing care needs and costs. Proactive interventions focused on patients with poor HRQOL may be an efficient approach to saving on healthcare costs and resource utilization.
Authors: Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths Journal: J Pediatr Gastroenterol Nutr Date: 2005-10 Impact factor: 2.839
Authors: Arlene C Gerson; Alicia Wentz; Allison G Abraham; Susan R Mendley; Stephen R Hooper; Robert W Butler; Debbie S Gipson; Marc B Lande; Shlomo Shinnar; Marva M Moxey-Mims; Bradley A Warady; Susan L Furth Journal: Pediatrics Date: 2010-01-18 Impact factor: 7.124
Authors: Eva Szigethy; Simona I Bujoreanu; Ada O Youk; John Weisz; David Benhayon; Diane Fairclough; Peter Ducharme; Joseph Gonzalez-Heydrich; David Keljo; Arvind Srinath; Athos Bousvaros; Margaret Kirshner; Melissa Newara; David Kupfer; David R DeMaso Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-05-10 Impact factor: 8.829
Authors: Angie Mae Rodday; Robert J Graham; Ruth Ann Weidner; Norma Terrin; Laurel K Leslie; Susan K Parsons Journal: J Pediatr Health Care Date: 2017-06-16 Impact factor: 1.812
Authors: James W Varni; Cristiane B Bendo; Robert J Shulman; Mariella M Self; Samuel Nurko; James P Franciosi; Miguel Saps; Shehzad Saeed; George M Zacur; Chelsea Vaughan Dark; John F Pohl Journal: J Pediatr Psychol Date: 2015-02-13
Authors: Jamie L Ryan; Meghan E McGrady; Shanna M Guilfoyle; Katherine Junger; Alex D Arnett; Avani C Modi Journal: Neurology Date: 2015-07-10 Impact factor: 9.910
Authors: Jamie L Ryan; Meghan E McGrady; Shanna M Guilfoyle; Katherine Follansbee-Junger; James L Peugh; Kristin A Loiselle; Alex D Arnett; Avani C Modi Journal: J Pediatr Psychol Date: 2015-10-26
Authors: Gertrude van den Brink; Luuk Stapersma; Hanan El Marroun; Jens Henrichs; Eva M Szigethy; Elisabeth Mwj Utens; Johanna C Escher Journal: BMJ Open Gastroenterol Date: 2016-03-02
Authors: Jonas Zeitz; Melike Ak; Séverine Müller-Mottet; Sylvie Scharl; Luc Biedermann; Nicolas Fournier; Pascal Frei; Valerie Pittet; Michael Scharl; Michael Fried; Gerhard Rogler; Stephan Vavricka Journal: PLoS One Date: 2016-06-22 Impact factor: 3.240